Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-020664
Filing Date
2017-08-18
Accepted
2017-08-18 11:41:24
Documents
1
Period of Report
2017-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4217
  Complete submission text file 0000899243-17-020664.txt   6217
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35726 | Film No.: 171040501

Mailing Address SNIPWEG 26 CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH GROWTH N V (Reporting) CIK: 0001259869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35726 | Film No.: 171040502

Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Issuer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations